Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 601–700 of 1,008
Trastoy, B., Lomino, J. V., Pierce, B. G., Carter, L. G., Günther, S., Giddens, J. P., Snyder, G. A., Weiss, T. M., Weng, Z., Wang, L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322908111 · Cited by 66
T-Bet+ IgM Memory Cells Generate Multi-lineage Effector B Cells
Kenderes, K. J., Levack, R. C., Papillion, A. M., Cabrera-Martinez, B., Dishaw, L. M., & Winslow, G. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.074 · Cited by 64
“Themechanismwhereby this apparent inhibition occurs is not yet known but may involve suppression via Fc receptors for IgM, IgG, or both (Nguyen et al., 2017; Nimmerjahn and Ravetch, 2008).”
BackgroundKLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B
Wijaya, R. S., Read, S. A., Schibeci, S., Eslam, M., Azardaryany, M. K., El-Khobar, K., van der Poorten, D., Lin, R., Yuen, L., Lam, V., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.012 · Cited by 62
B cell class switching in intestinal immunity in health and disease
Fleming, A., Castro‐Dopico, T., & Clatworthy, M. R. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13139 · Cited by 68
Chu, S. Y., Yeter, K. C., Kotha, R., Pong, E., Miranda, Y., Phung, S., Chen, H., Lee, S., Leung, I., Bonzon, C., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38334 · Cited by 61
Computationally Designed Bispecific Antibodies using Negative State Repertoires
Leaver-Fay, A., Froning, K. J., Atwell, S., Aldaz, H., Pustilnik, A., Lu, F., Huang, F., Yuan, R., Hassanali, S., Chamberlain, A. K., et al. (2016) · Structure · doi:10.1016/j.str.2016.02.013 · Cited by 62
Allie, S. R., & Randall, T. D. (2017) · Clinical Science · doi:10.1042/cs20160259 · Cited by 75
Gomez, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00175 · Cited by 66
McNally, A. K., & Anderson, J. M. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35280 · Cited by 59
“In terms of receptors for IgG, the CD32B inhibitory isoform of IgGRII known to be associated with down-regulation of the immune response (34) is readily detectable in cultures of IL-4-induced fusing macrophages/FBGC but is not apparent on C or PS.”
BackgroundGlycans – the third revolution in evolution
Lauc, G., Krištić, J., & ZoldoÅ¡, V. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00145 · Cited by 76
“However, different invaders (toxins, viruses, bacteria, fungi, parasites) require activation of different effector mechanisms, and this is where protein glycosylation seems to be essential (Nimmerjahn and Ravetch, 2008; Mihai and Nimmerjahn, 2012).”
BackgroundYersinia pestis: mechanisms of entry into and resistance to the host cell
Ke, Y., Chen, Z., & Yang, R. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00106 · Cited by 70
Zhou, S., Lv, J., Bu, D.-F., Yu, L., Yang, Y.-R., Zhao, J., Cui, Z., Yang, R., Zhao, M., & Zhang, H. (2009) · International Immunology · doi:10.1093/intimm/dxp113 · Cited by 60
Alsughayyir, J., Pettigrew, G. J., & Motallebzadeh, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01639 · Cited by 61
Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
Su, B., Dispinseri, S., Iannone, V., Zhang, T., Wu, H., Carapito, R., Bahram, S., Scarlatti, G., & Moog, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02968 · Cited by 73
Tuero, I., Mohanram, V., Musich, T., Miller, L., Vargas‐Inchaustegui, D. A., Demberg, T., Venzon, D. J., Kalisz, I., Kalyanaraman, V. S., Pal, R., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005101 · Cited by 63
Semmes, E. C., Miller, I. G., Wimberly, C. E., Phan, C. T., Jenks, J. A., Harnois, M. J., Berendam, S. J., Webster, H. S., Hurst, J. H., Kurtzberg, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156827 · Cited by 60
Li, F., & Liu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1083462 · Cited by 74
“The ADCC activity of mAbs is largely dependent on the CD16 expressed by NK cells (20).”
BackgroundCauvin, A. J., Peters, C., & Brennan, F. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417144-2.00019-6 · Cited by 77
“Even greater differences in Fc receptor expression, distribution, and internalization profiles between humans and mice also are observed [55] .”
BackgroundSpleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Bajpai, M., Chopra, P., Dastidar, S. G., & Ray, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.641 · Cited by 62
Jung, D.-J., An, J.-H., Kurokawa, K., Jung, Y.-C., Kim, M.-J., Aoyagi, Y., Matsushita, M., Takahashi, S., Lee, H., Takahashi, K., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201294 · Cited by 65
Antibody-mediated targeting of TNFR2 activates CD8 + T cells in mice and promotes antitumor immunity
Tam, E. M., Fulton, R. B., Sampson, J. F., Muda, M., Camblin, A. J., Richards, J. M. J., Koshkaryev, A., Tang, J., Kurella, V. B., Jiao, Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0720 · Cited by 67
Lee, C.-Y., Herant, M., & Heinrich, V. (2011) · Journal of Cell Science · doi:10.1242/jcs.078592 · Cited by 63
“…the neutrophil Fc receptors IIA (CD32A) and IIIB (CD16B), bearing in mind that constitutive expression of the highaffinity FcRI (CD64) is minimal on quiescent human neutrophils (Bredius et al., 1994; Williams et al., 2000; Kakinoki et al., 2004; Selvaraj et al., 2004; Nimmerjahn and Ravetch, 2008).”
BackgroundImmunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion
Farré, D., Martínez‐Vicente, P., Engel, P., & Angulo, A. (2017) · European Journal of Immunology · doi:10.1002/eji.201746984 · Cited by 65
Syrimi, E., Fennell, É., Richter, A. G., Vrljicak, P., Stark, R., Ott, S., Murray, P. G., Al‐Abadi, E., Chikermane, A., Dawson, P., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103215 · Cited by 63
The many faces of FcγRI: implications for therapeutic antibody function
Swisher, J. F. A., & Feldman, G. M. (2015) · Immunological Reviews · doi:10.1111/imr.12334 · Cited by 68
Lobigs, M., & Diamond, M. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.180 · Cited by 58
Chung, S., Lin, Y. L., Reed, C., Ng, C., Cheng, Z.-J. J., Malavasi, F., Yang, J., Quarmby, V. E., & Song, A. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.021 · Cited by 68
Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma
Yue, X., Ai, J., Xu, Y., Chen, Y., Huang, M., Yang, X., Hu, B., Zhang, H., He, C.-X., Yang, X., et al. (2017) · Hepatology · doi:10.1002/hep.29036 · Cited by 60
Peptibodies: An elegant solution for a long‐standing problem
Cavaco, M., Castanho, M. A. R. B., & Neves, V. (2018) · Peptide Science · doi:10.1002/bip.23095 · Cited by 57
Salazar, N., Carlson, J. C., Huang, K., Zheng, Y., Oderup, C., Gross, J. L., Jang, A., Burke, T. M., Lewén, S., Scholz, A., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.030 · Cited by 64
Mechanics of antigen extraction in the B cell synapse
Spillane, K. M., & Tolar, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.07.018 · Cited by 65
“17 μM)[132,133] and require multivalent interactions for triggering[134,135].”
BackgroundResistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Franssen, L. E., Stege, C. A. M., Zweegman, S., van de Donk, N. W. C. J., & Nijhof, I. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041195 · Cited by 69
“ADCC and ADCP are dependent on activation of the FcγRs on effector cells, such as macrophages and NK cells [85].”
BackgroundKumar, N. N., Pizzo, M. E., Nehra, G., Wilken-Resman, B., Boroumand, S., & Thorne, R. G. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00548 · Cited by 69
Syphilis vaccine: challenges, controversies and opportunities
Ávila‐Nieto, C., Pedreño-López, N., Mitjà, J., Clotet, B., Blanco, J., & Carrillo, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126170 · Cited by 68
Next generation of multispecific antibody engineering
Kéri, D., Walker, M., Singh, I., Nishikawa, K. K., & Garcés, F. (2023) · Antibody Therapeutics · doi:10.1093/abt/tbad027 · Cited by 80
Soto, L., Ferrier, A., Aravena, O., Fonseca, E. G., Berendsen, J., Biere, A., Bueno, D., Ramos, V., Aguillón, J. C., & Catalán, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00496 · Cited by 65
Tada, M., Ishii‐Watabe, A., Suzuki, T., & Kawasaki, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095787 · Cited by 62
Hu, X., Wu, J., Zhu, L., Wang, X., Xu, B., Wang, R., Ou, X., & Weng, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042439 · Cited by 57
“As the only known inhibitory FccR, FccRIIB has an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain, and thus it plays an important role in regulating the immune system [40] .”
BackgroundThe expanding field of platelet–bacterial interconnections
Kerrigan, S. W. (2015) · Platelets · doi:10.3109/09537104.2014.997690 · Cited by 57
Therapeutic implications of autoantibodies in rheumatoid arthritis
Aletaha, D., & Blüml, S. (2016) · RMD Open · doi:10.1136/rmdopen-2014-000009 · Cited by 62
Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing
Lee, P. W., Shukla, S., Wallat, J. D., Danda, C., Steinmetz, N. F., Maia, J. M., & Pokorski, J. K. (2017) · ACS Nano · doi:10.1021/acsnano.7b02786 · Cited by 61
Hamdan, F., Ylösmäki, E. O., Chiaro, J., Giannoula, Y., Long, M., Fusciello, M., Feola, S., Martins, B., Feodoroff, M., Antignani, G., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003000 · Cited by 57
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
Hasan, A., Al‐Ozairi, E., Albaqsumi, Z., Ahmad, R., & Al‐Mulla, F. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s280706 · Cited by 56
Bukhalid, R. A., Duvall, J. R., Lancaster, K. L., Catcott, K. C., Cetinbas, N. M., Monnell, T. E., Routhier, C. A., Thomas, J. D., Bentley, K. W., Collins, S. D., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2449 · Cited by 69
Sukumaran, S., Xue, B., Jusko, W. J., DuBois, D. C., & Almon, R. R. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00106.2010 · Cited by 58
Gat, O., Galen, J. E., Tennant, S. M., Simon, R., Blackwelder, W. C., Silverman, D. J., Pasetti, M. F., & Levine, M. M. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001373 · Cited by 58
“One possibility is that some antibodies in excess may compete or block specific phagocyte Fc receptors that endocytose or phagocytose antibody-coated microorganisms [55].”
BackgroundMolecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention
Stolz, C., & Schüler, M. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902878471 · Cited by 62
Catalán, D., Aravena, O., Sabugo, F., Wurmann, P., Soto, L., Kalergis, A. M., Cuchacovich, M., Aguillón, J. C., & P-07-088-F, M. N. O. I. A. I. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2985 · Cited by 61
“This characteristic confers an inhibitory function to the receptor which is essential in several checkpoint stages in which abnormal humoral responses are quenched by mechanisms that include the deletion of autoreactive clones and feedback inhibition of IgG secretion [3].”
BackgroundBaruah, K., Bowden, T. A., Krishna, B. A., Dwek, R. A., Crispin, M., & Scanlan, C. N. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.04.002 · Cited by 58
“The ability of an antibody to recruit the killing machinery of the cellular immune system is dependent on the interaction between the antibody Fc domain and Fc receptors found on cells such as macrophages and natural killer cells.(1) This antibody-dependent cellular cytotoxicity (ADCC) is required for the efficient el…”
BackgroundAn Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
Koerner, S., Andre, M. C., Leibold, J., Kousis, P. C., Kübler, A., Pal, M., Haen, S. P., Bühring, H.-J., Grosse-Hovest, L., Jung, G., et al. (2016) · Leukemia · doi:10.1038/leu.2016.194 · Cited by 56
OMIP‐051 – 28‐color flow cytometry panel to characterize B cells and myeloid cells
Liechti, T., & Roederer, M. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23689 · Cited by 59
A Sample-Sparing Multiplexed ADCP Assay
Butler, A. L., Fallon, J. K., & Alter, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01851 · Cited by 60
The Complex Association of FcγRIIb With Autoimmune Susceptibility
Verbeek, J. S., Hirose, S., & Nishimura, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02061 · Cited by 67
“In both humans and mice, the activating FcγRs are counterbalanced by one inhibitory single-chain low-affinity receptor FcγRIIb (FCGR2B or CD32B) with an inhibitory motif named immunoreceptor tyrosine-based inhibition motif (ITIM) within its cytoplasmic domain.”
BackgroundInfluentialDevelopment of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine
Hu, H., & Steinmetz, N. F. (2021) · Cancers · doi:10.3390/cancers13122909 · Cited by 59
“Further, IgG1 can fix and mediate antibody-dependent cell cytotoxicity (ADCC) of cancer cells through natural killer cells [39]; IgG2a/2b have the highest binding affinities to FcγRs and are particularly potent mediator of ADCC by myeloid cells, including neutrophils [40,41].”
BackgroundConvertino, I., Tuccori, M., Ferraro, S., Valdiserra, G., Cappello, E., Focosi, D., & Blandizzi, C. (2020) · Critical Care · doi:10.1186/s13054-020-03020-3 · Cited by 54
“which rely on cytokines and vasoactive mediators [37].”
BackgroundCao, J., Ji, L., Zhan, Y., Shao, X., Pengcheng, X., Wu, B., Chen, P., Cheng, L., Zhuang, X., Ou, Y., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01089-8 · Cited by 59
Du, F., Ye, Z., He, A., Yuan, J., Su, M., Jia, Q., Wang, H., Yang, P., Yang, Z., Ning, P., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.064 · Cited by 61
Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype
Rodrigo, W. W. S. I., Block, O. K. T., Lane, C., Sukupolvi-Petty, S., Goncalvez, A. P., Johnson, S., Diamond, M., Lai, C., Rose, R. C., Jin, X., et al. (2009) · Virology · doi:10.1016/j.virol.2009.09.024 · Cited by 55
“FcγRs comprise a multi-gene family of type 1 integral membrane glycoproteins (reviewed in: (Nimmerjahn and Ravetch, 2008)).”
BackgroundThe Contribution of Allergen-Specific IgG to the Development of Th2-Mediated Airway Inflammation
Williams, J. W., Tjota, M. Y., & Sperling, A. I. (2012) · Journal of Allergy · doi:10.1155/2012/236075 · Cited by 55
“The relevance of this effect may not be applicable to the development of allergic lung diseases because during secondary responses, ICs that bind to FcγRIII at a much higher affinity than free monomeric IgG are formed [16].”
BackgroundInfluentialCooper, D. L., Martin, S. G., Robinson, J. I., Mackie, S. L., Charles, C. J., Nam, J. L., Isaacs, J. D., Emery, P., & Morgan, A. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028918 · Cited by 55
Role of Inhibitory BCR Co-Receptors in Immunity
Tsubata, T. (2012) · Infectious Disorders - Drug Targets · doi:10.2174/187152612800564455 · Cited by 62
Clozapine-Induced Agranulocytosis and its Genetic Determinants
Opgen‐Rhein, C., & Dettling, M. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1101 · Cited by 57
CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity
Corrales‐Aguilar, E., Hoffmann, K., & Hengel, H. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0448-2 · Cited by 61
“1) [23, 27, 55].”
BackgroundInfluentialGardinassi, L. G., Dotz, V., Ederveen, A. L. H., de Almeida, R. P., Costa, C. H. N., Costa, D. L., de Jesus, A. R., Mayboroda, O. A., Garcia, G. R., Wuhrer, M., et al. (2014) · mBio · doi:10.1128/mbio.01844-14 · Cited by 62
Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts
Baldwin, W. M., Valujskikh, A., & Fairchild, R. L. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000262 · Cited by 62
Imbert, P. R. C., Sarić, A., Pedram, K., Bertozzi, C. R., Grinstein, S., & Freeman, S. A. (2020) · Current Biology · doi:10.1016/j.cub.2020.09.082 · Cited by 59
“In certain anti-inflammatory contexts, cytokines mediate the transcriptional upregulation of these inhibitory receptors [12].”
BackgroundLi, C., Zhu, S., Ma, C. D., & Wang, L. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07906 · Cited by 62
Hammers, C. M., Bieber, K., Kalies, K., Banczyk, D., Ellebrecht, C. T., Ibrahim, S. M., Zillikens, D., Ludwig, R. J., & Westermann, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100796 · Cited by 55
The Multiple Functions of B Cells in Chronic HBV Infection
Cai, Y., & Yin, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582292 · Cited by 62
Sun, W., Li, P., Wang, M., Xu, Y., Shen, D., Zhang, X., & Liu, Y. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109660 · Cited by 61
Antibody‐mediated phagocytosis in cancer immunotherapy
Wagoner, C. M. V., Rivera‐Escalera, F., Jaimes‐Delgadillo, N. C., Chu, C. C., Zent, C. S., & Elliott, M. R. (2023) · Immunological Reviews · doi:10.1111/imr.13265 · Cited by 58
“…(mFc γ RI, mFc γ RIV, and hFc γ RI) are constitutively saturated with monomeric IgG under steady-state conditions in the absence of antigen, 13,15 while low affinity Fc γ Rs are only capable of binding immune complexes through high avidity, multimeric interactions more typical during an…”
BackgroundGlial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology
Hartnell, I. J., Woodhouse, D., Jasper, W., Mason, L., Marwaha, P. K., Graffeuil, M., Lau, L. C., Norman, J. L., Chatelet, D. S., Buée, L., et al. (2023) · Brain · doi:10.1093/brain/awad309 · Cited by 64
Zhang, L., Liu, S., Wright, T. T., Shen, Z.-Y., Li, H., Zhu, W., Potempa, L. A., Ji, S., Szalai, A. J., & Wu, Y. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402909 · Cited by 54
“Copyright 2015 by The American Association of Immunologists, Inc. 0022-1767/15/$25.00 www.jimmunol.org/cgi/doi/10.4049/jimmunol.1402909 T cells express FcRs (28).”
BackgroundInfluentialVogelpoel, L. T. C., Hansen, I. S., Visser, M. W., Nagelkerke, S. Q., Kuijpers, T. W., Kapsenberg, M. L., de Jong, E. C., & den Dunnen, J. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.07.016 · Cited by 56
Karmakar, P. S., Lee, K., Sarkar, S., Wall, K. A., & Sucheck, S. J. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00528 · Cited by 55
SHIP2: Structure, Function and Inhibition
Thomas, M. P., Erneux, C., & Potter, B. V. L. (2017) · ChemBioChem · doi:10.1002/cbic.201600541 · Cited by 56
Anti‐retroviral antibody FcγR‐mediated effector functions
Bournazos, S., & Ravetch, J. V. (2017) · Immunological Reviews · doi:10.1111/imr.12482 · Cited by 61
Self-citationLee, J., Kang, H. A., Bae, J. S., Kim, K. D., Lee, K. H., Lim, K. J., Choo, M. J., & Chang, S.-J. (2018) · mAbs · doi:10.1080/19420862.2018.1440170 · Cited by 59
Chandler, K. B., Mehta, N., Leon, D. R., Suscovich, T. J., Alter, G., & Costello, C. E. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001185 · Cited by 60
Cenna, J. M., Tan, G. S., Papaneri, A. B., Dietzschold, B., Schnell, M. J., & McGettigan, J. P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.069 · Cited by 54
Bakchoul, T., Greinacher, A., Sachs, U. J., Krautwurst, A., Renz, H., Harb, H., Bein, G., Newman, P. J., & Santoso, S. (2013) · Blood · doi:10.1182/blood-2012-11-468561 · Cited by 54
Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes
Dutta, A., Bhagat, S., Paul, S., Katz, J. P., Sengupta, D., & Bhargava, D. K. (2023) · Vaccines · doi:10.3390/vaccines11061028 · Cited by 64
“Neutrophils express different types of FcR for IgG(FcγR) having subtypes capable of inducing FcγRI (CD64), FcγRIIa (CD32a), FcγRIIb (CD32b), FcγRIIc (CD32c), FcγRIIIa (CD16a), and FcγRIIIb (CD16b) having different holds for IgG1, IgG2, and IgG4 [89] in IgG-based cancer therapies.”
BackgroundEnhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment
Kohrt, H. E. K., Rajasekaran, N., Chester, C., Yonezawa, A., & Zhao, X. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s61292 · Cited by 65
Gonen, A., Hansen, L. F., Turner, W. W., Montano, E. N., Que, X., Rafia, A., Chou, M.-Y., Wiesner, P., Tsiantoulas, D., Corr, M., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053256 · Cited by 53
Mechanisms involved in antibody- and complement-mediated allograft rejection
Wasowska, B. A. (2010) · Immunologic Research · doi:10.1007/s12026-009-8136-3 · Cited by 61
“Only two types of cells do not co-express activating and inhibitory receptors: NK cells express exclusively FcγRIII, and B cells express inhibitory FcγRIIB [128,130].”
BackgroundProtein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus
Thammavongsa, V., Rauch, S., Kim, H. K., Missiakas, D. M., & Schneewind, O. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.11.051 · Cited by 55
Derer, S., Glorius, P., Schlaeth, M., Lohse, S., Klausz, K., Muchhal, U. S., Desjarlais, J. R., Humpe, A., Valerius, T., & Peipp, M. (2013) · mAbs · doi:10.4161/mabs.27457 · Cited by 61
Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry
Lippold, S., Nicolardi, S., Domínguez‐Vega, E., Heidenreich, A.-K., Vidarsson, G., Reusch, D., Haberger, M., Wuhrer, M., & Falck, D. (2019) · mAbs · doi:10.1080/19420862.2019.1636602 · Cited by 70
“The interaction of FcɣRIIIa with the Fc portion occurs in an asymmetrical 1:1 stoichiometry that precludes cellular activation in vivo by monomeric antibodies.(2,11) Thus, the translation of functional cellular assays is more straight-”
BackgroundInfluentialThe Current Landscape of Antibody-based Therapies in Solid Malignancies
Shah, A., Rauth, S., Aithal, A., Kaur, S., Ganguly, K., Orzechowski, C., Varshney, G. C., Jain, M., & Batra, S. K. (2021) · Theranostics · doi:10.7150/thno.52614 · Cited by 49
Gliddon, H. D., Kaforou, M., Alikian, M., Habgood-Coote, D., Zhou, C., Oni, T., Anderson, S. T. B., Brent, A., Crampin, A. C., Eley, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637164 · Cited by 62
Asrani, P., & Hassan, M. I. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03935-z · Cited by 53
“FcR mediated cytotoxicity can thus be controlled by blocking these receptors [81, 82].”
BackgroundNikkhoi, S. K., Li, G., Eleya, S., Yang, G., Vandavasi, V. G., & Hatefi, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039969 · Cited by 52
“IgG-based antibodies mediate the clearance of cancer cells via the engagement of CD16a receptors on natural killer cells and macrophages by eliciting ADCC and antibody-dependent cell phagocytosis (ADCP) (22, 23).”
BackgroundGoverna, V., de Oliveira, K. G., Bång-Rudenstam, A., Offer, S., Cerezo-Magaña, M., Li, J., Beyer, S., Johansson, M. C., Månsson, A., Edvardsson, C., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk1168 · Cited by 56
Cutting Edge: Expression of FcγRIIB Tempers Memory CD8 T Cell Function In Vivo
Starbeck-Miller, G. R., Badovinac, V. P., Barber, D. L., & Harty, J. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302232 · Cited by 54
Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation
He, L., Zhang, G., Liu, W., Gao, T., & Sheikh, K. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4926-14.2015 · Cited by 57
“…Fc Rs induce a sustained calcium influx that participates in inflammation and cytotoxicity via degranulation, phagocytosis, Ab-dependent cellular cytotoxicity (ADCC), and release of cytokines and other proinflammatory mediators (Nimmerjahn and Ravetch, 2007; Nimmerjahn and Ravetch, 2008).”
BackgroundYu, X., Holdorf, K., Kasper, B., Zillikens, D., Ludwig, R. J., & Petersen, F. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.230 · Cited by 52
Immunomagnetic enrichment and flow cytometric characterization of mouse microglia
Bedi, S. S., Smith, P., Hetz, R. A., Xue, H., & Cox, C. S. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.07.017 · Cited by 53
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript inhibitory FcγRIIB is able to induce endocytosis or phagocytosis after crosslinking (Nimmerjahn and Ravetch, 2008).”
BackgroundRecombinant Human Cytomegalovirus (HCMV) RL13 Binds Human Immunoglobulin G Fc
Cortese, M., Calò, S., D’Aurizio, R., Lilja, A., Pacchiani, N., & Merola, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050166 · Cited by 58
“These viral proteins interfere with the host receptors for the Fc portion (FccRs) of immunoglobulin G (IgG), expressed on the surface of all cell types in the innate and adaptive parts of the immune system [10].”
BackgroundM2b Monocytes Provoke Bacterial Pneumonia and Gut Bacteria–Associated Sepsis in Alcoholics
Tsuchimoto, Y., Asai, A., Tsuda, Y., Ito, I., Nishiguchi, T., Garcia, M. C., Suzuki, S., Kobayashi, M., Higuchi, K., & Suzuki, F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501369 · Cited by 55
The pro and anti-inflammatory activities of immunoglobulin G
Lux, A., Aschermann, S., Biburger, M., & Nimmerjahn, F. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117101 · Cited by 52
“There are several layers of defence mechanisms to prevent or at least to slow down pathogen replication in higher vertebrates. Besides physical barriers such as the skin, innate immune effector cells including macrophages, neutrophils and natural killer cells are equipped with a range of receptors that can directly re…”
BackgroundSelf-citation
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.